Citation: Bs. Jones et Me. Sobel, Modeling direction and intensity in semantically balanced ordinal scales: An assessment of congressional incumbent approval, AM J POL SC, 44(1), 2000, pp. 174-185
Authors:
Otis, CN
Krebs, PA
Quezado, MM
Albuquerque, A
Bryant, B
San Juan, X
Kleiner, D
Sobel, ME
Merino, MJ
Citation: Cn. Otis et al., Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behavior, HUMAN PATH, 31(2), 2000, pp. 233-238
Authors:
Sanz-Ortega, J
Bryant, B
Sanz-Esponera, J
Asenjo, JA
Saez, MC
Torres, A
Balibrea, JL
Sobel, ME
Merino, MJ
Citation: J. Sanz-ortega et al., LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer, PATH RES PR, 195(10), 1999, pp. 677-680
Authors:
Krebs, PA
Albuquerque, A
Quezado, M
Bryant, B
Sobel, ME
Merino, MJ
Otis, CN
Citation: Pa. Krebs et al., The use of microsatellite instability in the distinction between synchronous endometrial and colonic adenocarcinomas, INT J GYN P, 18(4), 1999, pp. 320-324
Authors:
Montuori, N
Muller, F
De Riu, S
Fenzi, G
Sobel, ME
Rossi, G
Vitale, M
Citation: N. Montuori et al., Laminin receptors in differentiated thyroid tumors: Restricted expression of the 67-kilodalton laminin receptor in follicular carcinoma cells, J CLIN END, 84(6), 1999, pp. 2086-2092
Authors:
Filie, AC
Chiesa, A
Bryant, BR
Merino, MJ
Sobel, ME
Abati, A
Citation: Ac. Filie et al., The tall cell variant of papillary carcinoma of the thyroid - Cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms, CANC CYTOP, 87(4), 1999, pp. 238-242
Authors:
Grizzle, W
Grody, WW
Noll, WW
Sobel, ME
Stass, SA
Trainer, T
Travers, H
Weedn, V
Woodruff, K
Citation: W. Grizzle et al., Recommended policies for uses of human tissue in research, education, and quality control, ARCH PATH L, 123(4), 1999, pp. 296-300
Authors:
Sanjuan, X
Bryant, BR
Sobel, ME
Merino, MJ
Citation: X. Sanjuan et al., Clonality analysis of benign parathyroid lesions by human androgen receptor (HUMARA) gene assay, ENDOCR PATH, 9(4), 1998, pp. 293-300